These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 607395)

  • 21. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
    Saxne T; Heinegård D; Wollheim FA
    Arthritis Rheum; 1987 Sep; 30(9):972-9. PubMed ID: 3663262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of collagen subtypes in synovial fluid sediments from arthritic patients.
    Cheung HS; Ryan LM; Kozin F; McCarty DJ
    Am J Med; 1980 Jan; 68(1):73-9. PubMed ID: 7350807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cephalexin in dogs and cats after oral, subcutaneous and intramuscular administration.
    Silley P; Rudd AP; Symington WM; Tait AJ
    Vet Rec; 1988 Jan; 122(1):15-7. PubMed ID: 3363802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum and joint levels of cefacetrile during its administration for septic arthritis].
    Blanc CH; Meyer-Brunot HG; Tosch W; Schelling JL
    Schweiz Med Wochenschr; 1978 Jul; 108(26):988-94. PubMed ID: 663591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
    Volck B; Johansen JS; Stoltenberg M; Garbarsch C; Price PA; Ostergaard M; Ostergaard K; Løvgreen-Nielsen P; Sonne-Holm S; Lorenzen I
    Osteoarthritis Cartilage; 2001 Apr; 9(3):203-14. PubMed ID: 11300743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
    Dalen D; Fry A; Campbell SG; Eppler J; Zed PJ
    Emerg Med J; 2018 Aug; 35(8):492-498. PubMed ID: 29914924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and synovial fluid osteocalcin in rheumatic diseases.
    Mattei JP; Ferrera V; Boutsen Y; Franceschi JP; Botti D; De Boissezon C; Kaphan G; Roux H
    Int J Clin Pharmacol Res; 1992; 12(3):103-7. PubMed ID: 1473875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fusidine level in the synovial fluid of the knee and in bone].
    Lozeron PP
    Z Unfallmed Berufskr; 1979; 72(3):114-7. PubMed ID: 543326
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis.
    Bertone AL; Jones RL; McIlwraith CW
    Am J Vet Res; 1988 Oct; 49(10):1681-7. PubMed ID: 3189982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cephalexin concentration in the human ejaculate following oral and parenteral administration.
    Dalet F; Marina S; Gimeno E; Pomerol J
    Andrologia; 1978; 10(2):142-8. PubMed ID: 646144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fundamental and clinical studies of sustained release cephalexin (L-Keflex) in the field of oral surgery (author's transl)].
    Morihana T; Ueda K; Muraoka M; Tsushima T; Kodama M; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1980 Apr; 33(4):514-21. PubMed ID: 6997536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Concentrations of ibuprofen and the protein and pH value of synovial fluid and plasma following oral administration of ibuprofen in patients with arthritis].
    Rau R; Berner G; Wagener HH; Vögtle-Junkert U
    Arzneimittelforschung; 1989 Sep; 39(9):1166-8. PubMed ID: 2590270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee.
    Kortekangas P; Aro HT; Tuominen J; Toivanen A
    Scand J Rheumatol; 1992; 21(6):283-8. PubMed ID: 1475638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Hori M; Okamoto K; Kohno S
    Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and synovial fluid analysis for diagnosing chronic periprosthetic infection in patients with inflammatory arthritis.
    Cipriano CA; Brown NM; Michael AM; Moric M; Sporer SM; Della Valle CJ
    J Bone Joint Surg Am; 2012 Apr; 94(7):594-600. PubMed ID: 22488615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraarticular volume and clearance in human synovial effusions.
    Wallis WJ; Simkin PA; Nelp WB; Foster DM
    Arthritis Rheum; 1985 Apr; 28(4):441-9. PubMed ID: 3885961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction.
    Månsson B; Geborek P; Saxne T
    Ann Rheum Dis; 1997 Feb; 56(2):91-6. PubMed ID: 9068280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of infections with oral cephalexin.
    Solberg CO; Schreiner A; Kalager T; Digranes A
    Chemotherapy; 1974; 20(5):315-20. PubMed ID: 4416627
    [No Abstract]   [Full Text] [Related]  

  • 40. Synovial fluid pH, cytologic characteristics, and gentamicin concentration after intra-articular administration of the drug in an experimental model of infectious arthritis in horses.
    Lloyd KC; Stover SM; Pascoe JR; Adams P
    Am J Vet Res; 1990 Sep; 51(9):1363-9. PubMed ID: 2204298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.